Table 1.
Characteristic | No. of patients (%) |
---|---|
Age, years | |
Median (range) | 63.0 (41–67) |
ECOG PS | |
0 | 9 (60.0) |
1 | 6 (40.0) |
Hormonal status | |
ER-positive and/or PgR-positive | 11 (73.3) |
ER-negative and PgR-negative | 4 (26.7) |
Metastatic site | |
Lung | 6 (40.0) |
Bone | 9 (60.0) |
Liver | 4 (26.7) |
Distant lymph nodes | 6 (40.0) |
Other | 3 (20.0) |
Prior chemotherapy for MBC | |
0 | 9 (60.0) |
1 | 6 (40.0) |
ECOG, Eastern Cooperative Oncology Group; ER, estrogen receptor; PgR, progesterone receptor; PS, performance status.